Found: 16
Select item for more details and to access through your institution.
Appendiceal Neuroendocrine Neoplasms: an Update for 2023.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 2, p. 114, doi. 10.1007/s11912-023-01484-4
- By:
- Publication type:
- Article
Falling Insulin Requirement in Pregnant Women With Diabetes Delivering Preterm: Prevalence, Predictors, and Consequences.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 6, p. e2237, doi. 10.1210/clinem/dgac159
- By:
- Publication type:
- Article
Prevalence and severity of diabetic retinopathy in pregnant women with diabetes—time to individualize photo screening frequency.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 7, p. 1, doi. 10.1111/dme.14819
- By:
- Publication type:
- Article
Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomography.
- Published in:
- Journal of Neuroendocrinology, 2023, v. 35, n. 8, p. 1, doi. 10.1111/jne.13322
- By:
- Publication type:
- Article
Increase of Ki‐67 index and influence on mortality in patients with neuroendocrine neoplasms.
- Published in:
- Journal of Neuroendocrinology, 2021, v. 33, n. 9, p. 1, doi. 10.1111/jne.13018
- By:
- Publication type:
- Article
Responses to Medical Treatment in 192 Patients with Pancreatic Neuroendocrine Neoplasms Referred to the Copenhagen Neuroendocrine Tumour Centre in 2000–2020.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1190, doi. 10.3390/cancers16061190
- By:
- Publication type:
- Article
Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 204, doi. 10.3390/cancers16010204
- By:
- Publication type:
- Article
Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 Patients.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 100, doi. 10.3390/cancers16010100
- By:
- Publication type:
- Article
Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 6, p. 806, doi. 10.1007/s11864-022-00969-x
- By:
- Publication type:
- Article
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Incidence, Clinical Presentation and Trends in Indication for Diagnostic Work-Up of Small Intestinal and Pancreatic Neuroendocrine Tumors.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 11, p. 2030, doi. 10.3390/diagnostics11112030
- By:
- Publication type:
- Article
Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 11, p. 881, doi. 10.3390/diagnostics10110881
- By:
- Publication type:
- Article
A short report of 50 patients with gastroenteropancreatic mixed neuroendocrine–non-neuroendocrine neoplasms (MiNEN).
- Published in:
- Acta Oncologica, 2021, v. 60, n. 6, p. 808, doi. 10.1080/0284186X.2021.1903077
- By:
- Publication type:
- Article
Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)--a multicentre, double-blind, randomised, placebo-controlled trial.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 1, p. 69, doi. 10.1002/ejhf.657
- By:
- Publication type:
- Article
Long-term L-Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double-blind, cross-over, placebo-controlled intervention study.
- Published in:
- Clinical Endocrinology, 2015, v. 83, n. 6, p. 931, doi. 10.1111/cen.12648
- By:
- Publication type:
- Article